Comparative effectiveness of long-term anti-obesity medications in routine clinical practice: a retrospective cohort study using real-world data
Chul-Gyu Kim, Jung-Min Koh, Kyun-Seop Bae · 2025
Read Comparative effectiveness of long-term anti-obesity medications in routine clinical practice: a retrospective cohort study using real-world data by Chul-Gyu Kim, Jung-Min Koh, Kyun-Seop Bae (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12806651.txt.
Description
Chul-Gyu Kim, Jung-Min Koh, and Kyun-Seop Bae compare three long-term anti-obesity drugs as used in real Korean clinic life. Orlistat, phentermine/topiramate, and liraglutide are all widely used, but head-to-head data from Asian practice were scarce. The team mined electronic health records from a tertiary hospital for adults prescribed any of the three between 2018 and 2025. Weight change at six months was the main measure, with blood sugar change and staying on the drug tracked.
There were 1,910 treatment episodes in all. Phentermine/topiramate beat orlistat on weight loss at six months, by about 1.6 percentage points of body weight. Its users were also more than twice as likely to lose at least 5% of body weight. Liraglutide matched orlistat on weight, with a trend to better blood sugar. Real-world results like these show what happens in ordinary care.
Catalog record
| CREATOR | Chul-Gyu Kim, Jung-Min Koh, Kyun-Seop Bae |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |